WNT5A and atherosclerosis: Based on the obtained data, our study aimed to evaluate the therapeutic potential of tetrandrine, in low and high doses, in vitamin D3/HCD-induced atherosclerosis rat model via regulating miRNA-34a and the Wnt5a/Ror2/NF-κB pathway.